No Data
No Data
Press Release Biocartis Group NV: Disclosure of Transparency Notification (Article 14, First Paragraph, of the Act of 2 May 2007 on the Disclosure of Large Shareholdings)
BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 10 January 2024, 23:00 CET Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 M
Press Release Biocartis Group NV: Announcement Regarding Enforcement by Secured Creditors
PRESS RELEASE REGULATED INFORMATION 31 October 2023, 15:30 CET ANNOUNCEMENT REGARDING ENFORCEMENT BY SECURED CREDITORS The Company's Secured Creditors have enforced their security over the shares of t
Press Release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla Presented at European Society of Molecular Oncology Congress (ESMO)
PRESS RELEASE 20 October 2023, 07:00 CEST Four Abstracts Showing Excellent Data for Idylla Presented at European Society of Molecular Oncology Congress (ESMO) Mechelen, Belgium, 20 October 2023 – Bioc
Press Release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month With Launch of Breast Cancer Portfolio
PRESS RELEASE 16 October 2023, 7:00 CEST Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio Mechelen, Belgium, 16 October 2023 – Biocartis Group NV (the 'Company' or
Press Release Biocartis Group NV: Biocartis Announces Expansion of Its Collaboration With APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit
PRESS RELEASE 12 October 2023, 7:00 CEST Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit Mechelen, Belgium, 12 October 2023
Press Release Biocartis Group NV: Biocartis 2023 Half-year Results Webcast on 26 September 2023
PRESS RELEASE REGULATED INFORMATION 21 September 2023, 07:00 CEST BIOCARTI
No Data